{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T07:58:32Z","timestamp":1785571112242,"version":"3.56.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s12098-026-06234-5","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:18:23Z","timestamp":1783477103000},"page":"38-47","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Long-Term Outcomes of Enzyme Replacement Therapy in Indian Patients with Gaucher Disease \u2013 A Multicentric Study"],"prefix":"10.1007","volume":"93","author":[{"given":"Neerja","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devi","family":"Saranya S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashank","family":"Koundinya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamta","family":"Muranjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amita","family":"Moirangthem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujatha","family":"Jagdeesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aabha","family":"Nagral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inusha","family":"Panigrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratna Dua","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchandra","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavna","family":"Dhingra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajnya","family":"Ranganath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeeva","family":"GN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonu","family":"Antony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubha","family":"Phadke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kausik","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheela","family":"Nampoothiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Bijarnia-Mahay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Motwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotsna","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parminder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. M.","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3315-9782","authenticated-orcid":false,"given":"Madhulika","family":"Kabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"6234_CR1","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","volume":"160","author":"J Charrow","year":"2000","unstructured":"Charrow J, Andersson HC, Kaplan P, et al. The gaucher registry: demographics and disease characteristics of 1698 patients with gaucher disease. Arch Intern Med. 2000;160:2835\u201343.","journal-title":"Arch Intern Med"},{"key":"6234_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s13312-018-1249-9","volume":"55","author":"RD Puri","year":"2018","unstructured":"Puri RD, Kapoor S, Kishnani PS, et al; Gaucher Disease Task Force. Diagnosis and management of gaucher disease in India \u2013 consensus guidelines of the Gaucher Disease Task Force of the Society for Indian Academy of Medical Genetics and the Indian Academy of Pediatrics. Indian Pediatr. 2018;55:143\u201353.","journal-title":"Indian Pediatr"},{"key":"6234_CR3","first-page":"e92009","volume":"17","author":"DG Powline","year":"2025","unstructured":"Powline DG, P G, Das T, Sahu S, Joel SM, Joy P. Genotype meets phenotype: unraveling Gaucher\u2019s genetic landscape in the Indian population. Cureus. 2025;17:e92009.","journal-title":"Cureus"},{"key":"6234_CR4","doi-asserted-by":"publisher","first-page":"P26","DOI":"10.1186\/gb-2011-12-s1-p26","volume":"12","author":"V Bisariya","year":"2011","unstructured":"Bisariya V, Mistry PK, Liu J, Chaudhari MR, Gupta N, Kabra M. The mutation spectrum in Indian patients with Gaucher disease. Genome Biol. 2011;12:P26.","journal-title":"Genome Biol"},{"key":"6234_CR5","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1002\/ajmg.a.63115","volume":"191","author":"M Venkatachari","year":"2023","unstructured":"Venkatachari M, Chakraborty S, Correa ARE, et al. The spectrum of neurological manifestations and genotype-phenotype correlation in Indian children with Gaucher disease. Am J Med Genet A. 2023;191:1038\u201343.","journal-title":"Am J Med Genet A"},{"key":"6234_CR6","doi-asserted-by":"crossref","unstructured":"Sheth J, Bhavsar R, Mistri M, et al. Gaucher disease: single gene molecular characterization of one-hundred Indian patients reveals novel variants and the most prevalent mutation. BMC Med Genet. 2019;20:31.","DOI":"10.1186\/s12881-019-0759-1"},{"key":"6234_CR7","doi-asserted-by":"publisher","first-page":"5767","DOI":"10.1182\/blood-2011-07-366955","volume":"118","author":"A Zimran","year":"2011","unstructured":"Zimran A, Brill-Almon E, Chertkoff R, et al. Pivotal trial with plant cell\u2013expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease. Blood. 2011;118:5767\u201373.","journal-title":"Blood"},{"key":"6234_CR8","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1016\/S0140-6736(14)61841-9","volume":"385","author":"TM Cox","year":"2015","unstructured":"Cox TM, Drelichman G, Cravo R, et al. Eliglustat compared with imiglucerase in patients with Gaucher\u2019s disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial. Lancet. 2015;385:2355\u201362.","journal-title":"Lancet"},{"key":"6234_CR9","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1007\/s12325-024-02881-2","volume":"41","author":"R Schiffmann","year":"2024","unstructured":"Schiffmann R, Mengel E, Wallace M, et al. Qualitative study of the patient experience with venglustat for Gaucher disease type 3 in a phase 2 open-label, multicenter, multinational study (LEAP). Adv Ther. 2024;41:2907\u201323.","journal-title":"Adv Ther"},{"key":"6234_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2024.108556","volume":"143","author":"B den Hollander","year":"2024","unstructured":"den Hollander B, Le HL, Swart EL, Bikker H, Hollak CEM, Brands MM. Clinical and preclinical insights into high-dose ambroxol therapy for Gaucher disease type 2 and 3: a comprehensive systematic review. Mol Genet Metab. 2024;143:108556.","journal-title":"Mol Genet Metab"},{"key":"6234_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2024.108515","volume":"142","author":"A H\u00f8j","year":"2024","unstructured":"H\u00f8j A, \u00d8rngreen MC, Naume MM, Lund AM. Hematopoietic stem cell transplantation or enzyme replacement therapy in Gaucher disease type 3. Mol Genet Metab. 2024;142:108515.","journal-title":"Mol Genet Metab"},{"key":"6234_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ymgme.2020.12.295","volume":"132","author":"NJ Weinreb","year":"2021","unstructured":"Weinreb NJ, Camelo JS Jr, Charrow J, McClain MR, Mistry P, Belmatoug N; International Collaborative Gaucher Group (ICGG) Gaucher Registry (NCT00358943) Investigators. Gaucher disease type 1 patients from the ICGG Gaucher registry sustain initial clinical improvements during twenty years of imiglucerase treatment. Mol Genet Metab. 2021;132:100\u201311.","journal-title":"Mol Genet Metab"},{"key":"6234_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/jpgm.JPGM_41_18","volume":"64","author":"M Muranjan","year":"2018","unstructured":"Muranjan M, Karande S. Enzyme replacement therapy in India: lessons and insights. J Postgrad Med. 2018;64:195\u20139.","journal-title":"J Postgrad Med"},{"key":"6234_CR14","unstructured":"Ministry of Health and Family Welfare, Government of India. National Policy for Rare Diseases 2021. New Delhi: MoHFW. 2021. Available at: National Policy for Rare Diseases 2021."},{"key":"6234_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","volume":"113","author":"NJ Weinreb","year":"2002","unstructured":"Weinreb NJ, Charrow J, Andersson HC, et al. Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher registry. Am J Med. 2002;113:112\u20139.","journal-title":"Am J Med"},{"key":"6234_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ymgme.2016.12.001","volume":"120","author":"A El-Beshlawy","year":"2017","unstructured":"El-Beshlawy A, Tylki-Szymanska A, Vellodi A, et al. Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher registry. Mol Genet Metab. 2017;120:47\u201356.","journal-title":"Mol Genet Metab"},{"key":"6234_CR17","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1515\/cclm-2020-0306","volume":"58","author":"E Lepe-Balsalobre","year":"2020","unstructured":"Lepe-Balsalobre E, Santotoribio JD, Nu\u00f1ez-Vazquez R, et al. Genotype\/phenotype relationship in Gaucher disease patients. Novel mutation in glucocerebrosidase gene. Clin Chem Lab Med. 2020;58:2017\u201324.","journal-title":"Clin Chem Lab Med"},{"key":"6234_CR18","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/archpedi.160.6.603","volume":"160","author":"P Kaplan","year":"2006","unstructured":"Kaplan P, Andersson HC, Kacena KA, Yee JD. The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis. Arch Pediatr Adolesc Med. 2006;160:603\u20138.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"6234_CR19","first-page":"499","volume":"53","author":"Z Arikan-Ayyildiz","year":"2011","unstructured":"Arikan-Ayyildiz Z, Y\u00fcce A, Emre S, Baysoy G, Saltik-Temizel IN, G\u00fcrakan F. Outcome of enzyme replacement therapy in Turkish patients with Gaucher disease: does late intervention affect the response? Turk J Pediatr. 2011;53:499\u2013507.","journal-title":"Turk J Pediatr"},{"key":"6234_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13123588","volume":"13","author":"D Elstein","year":"2024","unstructured":"Elstein D, Belmatoug N, Bembi B, et al; GOS Study Group. Twelve years of the Gaucher outcomes survey (GOS): insights, achievements, and lessons learned from a global patient registry. J Clin Med. 2024;13:3588.","journal-title":"J Clin Med"},{"key":"6234_CR21","doi-asserted-by":"publisher","first-page":"5113","DOI":"10.1007\/s00277-024-05918-2","volume":"103","author":"I Motta","year":"2024","unstructured":"Motta I, Delbini P, Scaramellini N, et al. Enzyme replacement therapy improves erythropoiesis and iron dysregulation in Gaucher disease. Ann Hematol. 2024;103:5113\u201321.","journal-title":"Ann Hematol"},{"key":"6234_CR22","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1365-2141.2009.07872.x","volume":"147","author":"PK Mistry","year":"2009","unstructured":"Mistry PK, Deegan P, Vellodi A, Cole JA, Yeh M, Weinreb NJ. Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis. Br J Haematol. 2009;147:561\u201370.","journal-title":"Br J Haematol"},{"key":"6234_CR23","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/jbmr.3734","volume":"34","author":"D Hughes","year":"2019","unstructured":"Hughes D, Mikosch P, Belmatoug N, et al. Gaucher disease in bone: from pathophysiology to practice. J Bone Miner Res. 2019;34:996\u20131013.","journal-title":"J Bone Miner Res"},{"key":"6234_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S1096-7192(02)00122-1","volume":"77","author":"PK Mistry","year":"2002","unstructured":"Mistry PK, Sirrs S, Chan A, et al. Pulmonary hypertension in type 1 Gaucher\u2019s disease: genetic and epigenetic determinants of phenotype and response to therapy. Mol Genet Metab. 2002;77:91\u20138.","journal-title":"Mol Genet Metab"},{"key":"6234_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/biom13030436","volume":"13","author":"P Szyma\u0144ska-Ro\u017cek","year":"2023","unstructured":"Szyma\u0144ska-Ro\u017cek P, Czartoryska B, Kleinotiene G, Lipi\u0144ski P, Tylki-Szyma\u0144ska A, \u0141ugowska A. A 20-year longitudinal study of plasma chitotriosidase activity in treated Gaucher disease type 1 and 3 patients\u2014a qualitative and quantitative approach. Biomolecules. 2023;13:436.","journal-title":"Biomolecules"},{"key":"6234_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0280-3","volume":"10","author":"NJ Weinreb","year":"2015","unstructured":"Weinreb NJ, Finegold DN, Feingold E, et al. Evaluation of disease burden and response to treatment in adults with type 1 Gaucher disease using a validated disease severity scoring system (DS3). Orphanet J Rare Dis. 2015;10:64.","journal-title":"Orphanet J Rare Dis"}],"container-title":["Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-026-06234-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12098-026-06234-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-026-06234-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T07:39:24Z","timestamp":1785569964000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12098-026-06234-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":26,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["6234"],"URL":"https:\/\/doi.org\/10.1007\/s12098-026-06234-5","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"14 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}